The ESCMID Study Group for Anaerobic Infections (ESGAI) is at the forefront of advancing research and knowledge on anaerobic pathogens. Bringing together an international community of experts, ESGAI is committed to:
Insight into the recent situation of metronidazole resistance and nim gene positivity in Bacteroides fragilis group isolates from Germany, Hungary, Italy and Slovenia.
Veloo ACM, Visnyovszki Á, Cordovana M, Ambretti S, Boiten K, Pranada AB, Jeverica S, Sárvári KP, Nagy E, Sóki J; ESCMID Study Group on Anaerobic Infections. Anaerobe. 2025 Dec;96:103014
Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag)
Buhl MEJ, Sunnerhagen T, Join-Lambert O, Morris T, Jeverica S, Assous MV, Toprak NU, Alcalá-Hernandez L, Lienhard R, Veloo ACM, Cruz H, Sóki J, Novak A, Mazzariol A, Wybo I, Dumont Y, Justesen US; ReSuBacfrag Study Group; ESGAI. Int J Antimicrob Agents. 2024 Sep;64(3):107241
Molecular characterization and antibiotic resistance of clinical Bacteroides and related genera from a tertiary care center in Türkiye
Demir M, Soki J, Tanrıverdi ES, Özkul C, Mahmood B, Otlu B, Hazırolan G; ESCMID Study Group for Anaerobic Infections (ESGAI). Anaerobe. 2024 Sep 24;90:102912
If you have questions or comments for our study group, we warmly invite you to contact us!
Registration for ESCMID Global 2026 in Munich is now open.
Register now to get the early registration fee and attend the world’s most eminent event in the field of infection.
